Cargando…

Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis

INTRODUCTION: Alveolar air leak is a common and troublesome complication after pulmonary resection because it can lead to longer hospital stay and chest tube drainage time. AIM: As fibrin sealants are useful in the management of alveolar air leaks, we evaluated their benefit in patients undergoing p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jakraphan, Laohathai, Sira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809184/
https://www.ncbi.nlm.nih.gov/pubmed/36643342
http://dx.doi.org/10.5114/kitp.2022.122087
_version_ 1784863070103797760
author Yu, Jakraphan
Laohathai, Sira
author_facet Yu, Jakraphan
Laohathai, Sira
author_sort Yu, Jakraphan
collection PubMed
description INTRODUCTION: Alveolar air leak is a common and troublesome complication after pulmonary resection because it can lead to longer hospital stay and chest tube drainage time. AIM: As fibrin sealants are useful in the management of alveolar air leaks, we evaluated their benefit in patients undergoing pulmonary resection. MATERIAL AND METHODS: This retrospective study included patients who underwent pulmonary resection in our hospital between 2016 and 2021. We grouped patients on the basis of whether fibrin sealant was used during surgery and compared outcomes between those with (fibrin sealant group) and without (control group) sealant use after propensity score matching (1 : 1). RESULTS: During the study period, 375 patients underwent pulmonary resection; of these, fibrin sealant was applied at the staple line in 107 patients (fibrin sealant group), whereas sealant was not used in 268 patients (control group). After propensity score matching (1 : 1), there were 95 patients in both groups. There were no differences between the two groups in duration of chest tube drainage (3 days vs. 3 days; p = 0.753) or length of hospital stay (5 days vs. 4 days; p = 0.499). However, the sealant group showed higher cost of hospitalization (USD 4,360 vs. 3,614; p < 0.001). Multivariate analysis for identifying risk factors of persistent air leak revealed that male sex and chronic obstructive pulmonary disease were associated. CONCLUSIONS: Our results indicate that application of fibrin sealant was not effective in reducing length of hospital stay, duration of chest drains or air leakage.
format Online
Article
Text
id pubmed-9809184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-98091842023-01-12 Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis Yu, Jakraphan Laohathai, Sira Kardiochir Torakochirurgia Pol Original Paper INTRODUCTION: Alveolar air leak is a common and troublesome complication after pulmonary resection because it can lead to longer hospital stay and chest tube drainage time. AIM: As fibrin sealants are useful in the management of alveolar air leaks, we evaluated their benefit in patients undergoing pulmonary resection. MATERIAL AND METHODS: This retrospective study included patients who underwent pulmonary resection in our hospital between 2016 and 2021. We grouped patients on the basis of whether fibrin sealant was used during surgery and compared outcomes between those with (fibrin sealant group) and without (control group) sealant use after propensity score matching (1 : 1). RESULTS: During the study period, 375 patients underwent pulmonary resection; of these, fibrin sealant was applied at the staple line in 107 patients (fibrin sealant group), whereas sealant was not used in 268 patients (control group). After propensity score matching (1 : 1), there were 95 patients in both groups. There were no differences between the two groups in duration of chest tube drainage (3 days vs. 3 days; p = 0.753) or length of hospital stay (5 days vs. 4 days; p = 0.499). However, the sealant group showed higher cost of hospitalization (USD 4,360 vs. 3,614; p < 0.001). Multivariate analysis for identifying risk factors of persistent air leak revealed that male sex and chronic obstructive pulmonary disease were associated. CONCLUSIONS: Our results indicate that application of fibrin sealant was not effective in reducing length of hospital stay, duration of chest drains or air leakage. Termedia Publishing House 2022-12-16 2022-12 /pmc/articles/PMC9809184/ /pubmed/36643342 http://dx.doi.org/10.5114/kitp.2022.122087 Text en Copyright: © 2022 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Yu, Jakraphan
Laohathai, Sira
Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title_full Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title_fullStr Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title_full_unstemmed Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title_short Effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
title_sort effectiveness of fibrin sealant after pulmonary resection: a propensity score matching analysis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9809184/
https://www.ncbi.nlm.nih.gov/pubmed/36643342
http://dx.doi.org/10.5114/kitp.2022.122087
work_keys_str_mv AT yujakraphan effectivenessoffibrinsealantafterpulmonaryresectionapropensityscorematchinganalysis
AT laohathaisira effectivenessoffibrinsealantafterpulmonaryresectionapropensityscorematchinganalysis